Cargando…

Overexpression of GSE1 Related to Trastuzumab Resistance in Gastric Cancer Cells

Gastric cancer is one of the most prevalent human cancers with poor prognosis. Trastuzumab is a well-used targeted drug for gastric cancer with HER2 amplification. Trastuzumab resistance restrains the clinical use of trastuzumab. In this study, we reported human Gse1 coiled-coil protein (GSE1) promo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wenbin, Wang, Shuanhu, Xu, A. man, Yuan, Xiao, Huang, Liguo, Li, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875631/ https://www.ncbi.nlm.nih.gov/pubmed/33623790 http://dx.doi.org/10.1155/2021/8834923

Ejemplares similares

GSE says goodbye to paper!
Publicado: (2008)

GSE news and editorial announcements
Publicado: (2008)

GSE moves to open access publishing
Publicado: (2008)

Histological and Pathological Assessment of miR-204 and SOX4 Levels in Gastric Cancer Patients
por: Yuan, Xiao, et al.
Publicado: (2017)

A Mitochondria-Dependent Pathway Mediates the Apoptosis of GSE-Induced Yeast
por: Cao, Sishuo, et al.
Publicado: (2012)

GSE moves to a new system of submission
Publicado: (2005)

Nestin overexpression reduces the sensitivity of gastric cancer cells to trastuzumab
por: Wei, Yi-Chou, et al.
Publicado: (2023)

Identification and Pleiotropic Effect Analysis of GSE5 on Rice Chalkiness and Grain Shape
por: Jiang, Liangrong, et al.
Publicado: (2022)

Testing gene set enrichment for subset of genes: Sub-GSE
por: Yan, Xiting, et al.
Publicado: (2008)

Inhibitory effect of grapefruit seed extract (GSE) on avian pathogens
por: KOMURA, Miyuki, et al.
Publicado: (2019)

Enhanced Expression of CNTD2/CCNP Predicts Poor Prognosis in Bladder Cancer Based on the GSE13507
por: Gong, Mancheng, et al.
Publicado: (2021)

PBX3 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition
por: Wang, Shuanhu, et al.
Publicado: (2016)

GSE4, a Small Dyskerin- and GSE24.2-Related Peptide, Induces Telomerase Activity, Cell Proliferation and Reduces DNA Damage, Oxidative Stress and Cell Senescence in Dyskerin Mutant Cells
por: Iarriccio, Laura, et al.
Publicado: (2015)

GSE is now an open access journal published by BioMed Central
por: Hayes, Hélène, et al.
Publicado: (2009)

GSE Is a Maternal Factor Involved in Active DNA Demethylation in Zygotes
por: Hatanaka, Yuki, et al.
Publicado: (2013)

Molecular Mechanisms of Trastuzumab Resistance in HER2 Overexpressing Breast Cancer
por: Fiszman, Gabriel L., et al.
Publicado: (2011)

Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells
por: Huang, Mingyao, et al.
Publicado: (2022)

Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers
por: Wu, Yanyuan, et al.
Publicado: (2020)

GSE’s 50th anniversary: where do we go from now?
Publicado: (2019)

GSE1 links the HDAC1/CoREST co-repressor complex to DNA damage
por: Vcelkova, Terezia, et al.
Publicado: (2023)

Conversion therapy for advanced gastric cancer with trastuzumab combined with chemotherapy: A case report
por: Xiao, Shuo-Meng, et al.
Publicado: (2018)

Circular RNA circGSE1 Promotes Cervical Cancer Progression Through miR-138-5p/Vimentin
por: Fan, Suzhen, et al.
Publicado: (2020)

The Effectiveness of Trastuzumab Combined with Sequential Chemotherapy for Metastatic Gastric Carcinoma with Overexpression of HER2
por: Saavedra Santa Gadea, Omar, et al.
Publicado: (2017)

CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer
por: Xing, Fei, et al.
Publicado: (2023)

A CT-based radiomics signature for prediction of HER2 overexpression and treatment efficacy of trastuzumab in advanced gastric cancer
por: Ma, Tingting, et al.
Publicado: (2022)

Synergistic antitumor effect of the anti-ErbB2 antibodies trastuzumab and H2-18 on trastuzumab-resistant gastric cancer cells
por: Wang, Chao, et al.
Publicado: (2021)

Disrupting Circadian Rhythm via the PER1–HK2 Axis Reverses Trastuzumab Resistance in Gastric Cancer
por: Wang, Jiao, et al.
Publicado: (2022)

Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML
por: Nicosia, Luciano, et al.
Publicado: (2021)

Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer
por: Arienti, Chiara, et al.
Publicado: (2016)

Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer
por: Yu, Chaoran, et al.
Publicado: (2018)

Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer
por: Yang, Guangda, et al.
Publicado: (2019)

Genetic Suppressor Element 1 (GSE1) Promotes the Oncogenic and Recurrent Phenotypes of Castration-Resistant Prostate Cancer by Targeting Tumor-Associated Calcium Signal Transducer 2 (TACSTD2)
por: Bamodu, Oluwaseun Adebayo, et al.
Publicado: (2021)

Dicer increases the indication for trastuzumab treatment in gastric cancer patients via overexpression of human epidermal growth factor receptor 2
por: Wu, Jianhua, et al.
Publicado: (2021)

Circular RNA circGSE1 promotes angiogenesis in ageing mice by targeting the miR-323-5p/NRP1 axis
por: Qiu, Jiacong, et al.
Publicado: (2022)

Identification of Pivotal Genes and Pathways in Osteoarthritic Degenerative Meniscal Lesions via Bioinformatics Analysis of the GSE52042 Dataset
por: Huan, Xu, et al.
Publicado: (2019)

ERBB2D16 Expression in HER2 Positive Gastric Cancer Is Associated With Resistance to Trastuzumab
por: Wang, Shuo, et al.
Publicado: (2022)

A Retrospective Comparison of Trastuzumab Plus Cisplatin and Trastuzumab Plus Capecitabine in Elderly HER2-Positive Advanced Gastric Cancer Patients
por: Zhu, Bo, et al.
Publicado: (2015)

Corrigendum to “Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer”
por: Yang, Guangda, et al.
Publicado: (2020)

Antiproliferative and Apoptotic Effects Triggered by Grape Seed Extract (GSE) versus Epigallocatechin and Procyanidins on Colon Cancer Cell Lines
por: Dinicola, Simona, et al.
Publicado: (2012)

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
por: Natoli, Clara, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2idnmb3btekbn757ssplgtqvi6